Search results
Results from the WOW.Com Content Network
Tedizolid phosphate is a phosphate ester prodrug of the active compound tedizolid. It was developed by Cubist Pharmaceuticals , following acquisition of Trius Therapeutics (originator: Dong-A Pharmaceuticals), and is marketed for the treatment of acute bacterial skin and skin structure infections (also known as complicated skin and skin ...
Additionally, Tedizolid was shown to have fewer treatment-related side effects than linezolid and significantly fewer GI side effects. [6] Trius was planning the second Phase 2 trial and expects to report results around the end of Q1 2013 and planned to submit an NDA to the FDA for the drug in the second half of 2013. [7]
Cubist Pharmaceuticals to Acquire Trius Therapeutics Adds Highly Complementary, Late-Stage Antibiotic Candidate, Tedizolid, and Bolsters Cubist's Global Leadership in the Acute Care/Hospital ...
Tedizolid mops the floor with its competition. The biotech sector can occasionally throw a curveball at investors. For Trius Therapeutics shareholders, they were staring at a meaty fastball right ...
The following other wikis use this file: Usage on el.wikipedia.org Τεντιζολίδη; Usage on eo.wikipedia.org Oksazolidinono; Usage on es.wikipedia.org
Tedizolid is an oxazolidinone antibiotic developed by Dong-A ST, the specialty pharmaceuticals arm of Dong-A Socio Holdings, to treat patients with acute bacterial skin and skin structure infections. [209] Gemigliptin is a dipeptidyl peptidase-4 inhibitor developed by LG Life Sciences to treat hyperglycemia in patients with type 2 diabetes ...
Image credits: Green____cat Cyber and media psychologist Mayra Ruiz-McPherson, PhD(c), MA, MFA, explains that broadly speaking, "negative news" can describe two kinds of events and happenings ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!